Description
Ask your pharmacist about this product, Incorrect use could be harmful.
Glycoprep Orange is indicated for bowel emptying and cleansing by means of total gastrointestinal tract perfusion in preparation for gastrointestinal examination (such as colonoscopy, barium enema x-ray examination), prior to intravenous pyelograms (IVP) or colorectal surgery.
Directions
Patient instructions may be found on the carton and in the end of this consumer medicine information leaflet. In some circumstances, your doctor may choose to modify these dose instructions.
Follow all directions given to you by your doctor or pharmacist carefully. They may differ from the information contained in this leaflet. If you do not understand the instructions on the carton or in this leaflet, ask your doctor or pharmacist for help.
Warnings
GLYCOPREP ORANGE: should be administered with caution in patients with severe ulcerative colitis, those with a stoma, pre-existing electrolyte disturbances, dehydration, undiagnosed abdominal pain, congestive heart failure or diabetics.
GLYCOPREP ORANGE: should be administered with caution and under careful observation to patients with impaired gag reflex, who are semi-unconscious, who are prone to regurgitation or aspiration, and particularly those with nasogastric intubation. If administered via nasogastric intubation, proper hydration should be ensured.
GLYCOPREP ORANGE: should be administered with caution in patients with congestive heart failure and pre-existing electrolyte disturbances. These patients should be monitored.
GLYCOPREP ORANGE: should be administered with caution to patients using calcium channel blockers, diuretics or other medications that may affect electrolyte serum levels and exacerbate volume depletion. These patients should be monitored.
GLYCOPREP ORANGE: may cause bloating, distension or abdominal pain, especially if administered by nasogastric tube. This medicine may not be right for you. Read the label before purchase. Follow the directions for use. Incorrect use could be harmful. If symptoms persist talk to your health professional.
Ingredients
The active ingredients are: macrogol 3350 has a chemical formula of HOCH2 [CH2OCH2]m. CH2OH (where 'm' equals 45 to 70).
Sodium chloride has a chemical formula of NaCl, a MW of 58.44 and a CAS No. 7647-14-5.
Potassium chloride has a chemical formula of KCl, a MW of 74.6 and a CAS No. 7447-40-7.
Sodium sulfate has a chemical formula of Na2SO4, a MW of 142.0 and a CAS No.7757-82-6.
Each 70 g sachet contains macrogol 3350 (polyethylene glycol) 52.9 g, potassium chloride 740 mg, sodium chloride 2.6 g and sodium sulfate 5.6 g, as active ingredients. Total sodium content in 70 g sachet is 2.86 g.
Storage
Store as directed
$9.99
Glycoprep Orange 70g Sachet
This is a PHARMACIST ONLY MEDICINE and our friendly pharmacist will call you to confirm it is the right product for your needs.
Size: 70g Sachet
Description
Ask your pharmacist about this product, Incorrect use could be harmful.
Glycoprep Orange is indicated for bowel emptying and cleansing by means of total gastrointestinal tract perfusion in preparation for gastrointestinal examination (such as colonoscopy, barium enema x-ray examination), prior to intravenous pyelograms (IVP) or colorectal surgery.
Directions
Patient instructions may be found on the carton and in the end of this consumer medicine information leaflet. In some circumstances, your doctor may choose to modify these dose instructions.
Follow all directions given to you by your doctor or pharmacist carefully. They may differ from the information contained in this leaflet. If you do not understand the instructions on the carton or in this leaflet, ask your doctor or pharmacist for help.
Warnings
GLYCOPREP ORANGE: should be administered with caution in patients with severe ulcerative colitis, those with a stoma, pre-existing electrolyte disturbances, dehydration, undiagnosed abdominal pain, congestive heart failure or diabetics.
GLYCOPREP ORANGE: should be administered with caution and under careful observation to patients with impaired gag reflex, who are semi-unconscious, who are prone to regurgitation or aspiration, and particularly those with nasogastric intubation. If administered via nasogastric intubation, proper hydration should be ensured.
GLYCOPREP ORANGE: should be administered with caution in patients with congestive heart failure and pre-existing electrolyte disturbances. These patients should be monitored.
GLYCOPREP ORANGE: should be administered with caution to patients using calcium channel blockers, diuretics or other medications that may affect electrolyte serum levels and exacerbate volume depletion. These patients should be monitored.
GLYCOPREP ORANGE: may cause bloating, distension or abdominal pain, especially if administered by nasogastric tube. This medicine may not be right for you. Read the label before purchase. Follow the directions for use. Incorrect use could be harmful. If symptoms persist talk to your health professional.
Ingredients
The active ingredients are: macrogol 3350 has a chemical formula of HOCH2 [CH2OCH2]m. CH2OH (where 'm' equals 45 to 70).
Sodium chloride has a chemical formula of NaCl, a MW of 58.44 and a CAS No. 7647-14-5.
Potassium chloride has a chemical formula of KCl, a MW of 74.6 and a CAS No. 7447-40-7.
Sodium sulfate has a chemical formula of Na2SO4, a MW of 142.0 and a CAS No.7757-82-6.
Each 70 g sachet contains macrogol 3350 (polyethylene glycol) 52.9 g, potassium chloride 740 mg, sodium chloride 2.6 g and sodium sulfate 5.6 g, as active ingredients. Total sodium content in 70 g sachet is 2.86 g.
Storage
Store as directed
Related products